Digital disruption, AMNOG and cancer drugs, AZ and its pipeline and more

PME Pharmaceutical Market Europe May 2014Taking aim at digital disruption to pharma the May issue of PME was out this week in both its print and online incarnations.

The issue also featured an exclusive interview with AstraZeneca’s VP of oncology Susan Galbraith who talked about the company’s pipeline prospects – a topic that shortly after the interview was conducted took on added significance.

It was also time to update our Top Pharma List, detailing the industry’s top performing companies.

Elsewhere PME included insights on topics such as patient-relevant outcomes in Germany’s HTA process, key account management and the new collaborative approaches pharma is taking to R&D.

• Read the May 2014 issue of PME online

Advertisements

, , , , , ,

  1. Leave a comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: